Latest Materials News

International Graphite's Springdale Project achieves over 99.95% purity in graphite purification tests coordinated by Marubeni, signaling strong potential for battery market supply.

BlueScope Steel reported steady revenue of $8.59 billion for the first half of FY2025, maintaining solid earnings despite challenging raw material costs and subdued housing demand. The company’s diversified operations and ongoing capital investments underpin its resilience amid market headwinds.

BlueScope Steel reported a resilient $309 million underlying EBIT for 1H FY2025 despite depressed steel spreads, announcing a 30 cents per share interim dividend and extending its buy-back program. The company is targeting a $500 million incremental EBIT uplift by 2030 through cost initiatives and strategic growth projects.

Bluescope Steel Limited has announced a fully franked interim dividend of AUD 0.30 per share, reflecting confidence in its financial position for the half-year ending December 2024.

The a2 Milk Company Limited has reported solid revenue and profit growth for the half-year ending December 2024, alongside a confident dividend declaration reflecting its strengthened financial position.

Entyr Limited has extended the closing date for its capital raising offers to 3 March 2025, providing investors additional time to participate in new share and option subscriptions.

Osteopore Limited has drawn down A$2 million from the first tranche of its redeemable convertible notes, using the proceeds to repay existing loans and support ongoing business activities.

The Calmer Co. International Limited has secured a $2.64 million FJD loan from Fiji Development Bank to acquire a key Navua facility, marking a strategic step to bolster its kava processing and staff infrastructure.

Eumundi Group has officially been acquired by SEQ Hospitality Group, with shareholders receiving A$1.62 per share and significant board changes announced. The company is set to be delisted from the ASX imminently.

Norwood Systems has extended its cash drawdown facility for the sixth time, increasing the principal to $732,189.69 and pushing the repayment deadline to late February 2025.

Avecho Biotechnology has responded to an ASX price query, confirming no undisclosed information exists to explain recent trading spikes, while highlighting market speculation linked to its Phase III CBD insomnia trial.

Macarthur Minerals Limited reported a comprehensive loss of AUD 252,771 for Q4 2024, marking a sharp reversal from the prior year's profit. The company is navigating reduced exploration spending and strategic asset sales while facing ongoing funding challenges.